# Patient-Derived Organoid **Entity class:** Experimental model **Domain:** Organoid science / Precision medicine **Maturity:** Developed ## Definition A patient-derived organoid is grown from a person's cells to preserve selected genetic and phenotypic features of that person's tissue or disease. ## Mechanism and significance These models can compare treatment responses outside the body, yet sampling, culture conditions, missing vasculature, and immune context limit direct translation to clinical outcome. ## Relationships - **Research dossier:** [[research/ASI and RSI Timeline Research Moonshots|ASI and RSI Timeline Research Moonshots]] - **Ontology route:** [[ASI and RSI Timeline Ontology#Computational Biology and Virtual Cells|Computational Biology and Virtual Cells]] - **Primary fields:** [[AI-Driven Biology]] · [[Cellular Digital Twins]] · [[Computational Biology]] - **Adjacent concepts:** [[Lymph-Node Organoid]] · [[Pluripotent Stem Cell]] · [[Animal-Free Toxicity Testing]] · [[Parallel Bio]] ## Sources and provenance - [[research/ASI and RSI Timeline Research Moonshots|ASI and RSI Timeline Research Moonshots]] — immediate source for this node's role in the broadcast research map. ## Evidence boundary The research dossier establishes why this entity or concept belongs in the Moonshots ontology. Time-sensitive organizational, product, policy, and performance claims should be checked against the linked primary source or a current authoritative source before reuse as settled fact. ## Simple Reminders, Quotations, and Thoughts > Parallel Bio uses pluripotent stem cells to grow human lymph-node organoids and test drugs in parallel. The organoids are designed to replace some animal trials by predicting human drug response and toxicity more directly than experiments in mice. > **— Adapted from Richard Socher**, *MOONSHOTS Live, October 2026* [[reminders/Biotechnology/Human Organoids Can Outpredict Animal Trials by Richard Socher|Human Organoids Can Outpredict Animal Trials by Richard Socher]]